Viewing Study NCT01009203


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-31 @ 4:56 AM
Study NCT ID: NCT01009203
Status: TERMINATED
Last Update Posted: 2015-08-10
First Post: 2009-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Sponsor: New Mexico Cancer Research Alliance
Organization: